Biology Reference
In-Depth Information
References
Abate DA, Watanabe S, Mocarski ES (2004) Major human cytomegalovirus structural protein
pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response.
J Virol 78:10995-11006
Abenes G, Lee M, Haghjoo E, Tong T, Zhan X, Liu F (2001) Murine cytomegalovirus open reading
frame M27 plays an important role in growth and virulence in mice. J Virol 75:1697-1707
Adam SG, Caraux A, Fodil-Cornu N, Loredo-Osti JC, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S,
Guenet JL, Vidal SM, Colucci F (2006) Cmv4, a new locus linked to the NK cell gene
complex, controls innate resistance to cytomegalovirus in wild-derived mice. J Immunol
176:5478-5485
Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, Fruh K (1996) Human cytomegalovirus
inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A
93:10990-10995
Andrejeva J, Childs KS, Young DF, Carlos TS, Stock N, Goodbourn S, Randall RE (2004) The V
proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its acti-
vation of the IFN-beta promoter. Proc Natl Acad Sci U S A 101:17264-17269
Antrobus RD, Khan N, Hislop AD, Montamat-Sicotte D, Garner LI, Rickinson AB, Moss PA,
Willcox BE (2005) Virus-specific cytotoxic T lymphocytes differentially express cell-surface
leukocyte immunoglobulin-like receptor-1, an inhibitory receptor for class I major histocom-
patibility complex molecules. J Infect Dis 191:1842-1853
Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL (2002) Direct recognition of cytomega-
lovirus by activating and inhibitory NK cell receptors. Science 296:1323-1326
Arav-Boger R, Willoughby RE, Pass RF, Zong JC, Jang WJ, Alcendor D, Hayward GS
(2002) Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-
alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis
186:1057-1064
Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS, Diener-West M,
Landini MP (2006) Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor
receptor) and outcome of congenital CMV infection. J Infect Dis 194:464-473
Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J,
Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O
(2005) Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat
Immunol 6:515-523
Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, Messerle M, Hengel H (2002)
Identification and expression of human cytomegalovirus transcription units coding for two
distinct Fcgamma receptor homologs. J Virol 76:8596-8608
Bale JF Jr, Petheram SJ, Robertson M, Murph JR, Demmler G (2001) Human cytomegalovirus
a sequence and UL144 variability in strains from infected children. J Med Virol 65:90-96
Barel MT, Pizzato N, Le Bouteiller P, Wiertz EJ, Lenfant F (2006) Subtle sequence variation
among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-
mediated degradation. Int Immunol 18:173-182
Bartee E, McCormack A, Fruh K (2006) Quantitative membrane proteomics reveals new cellular
targets of viral immune modulators. PLoS Pathog 2:e107
Basta S, Bennink JR (2003) A survival game of hide and seek: cytomegaloviruses and MHC class I
antigen presentation pathways. Viral Immunol 16:231-242
Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells
and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727-729
Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC
class-I antigens. Nature 331:269-272
Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF
(1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of
human cytomegalovirus. J Immunol 162:6967-6970
